REQUEST A DEMO
Total
USD $0.00
Search more companies

Nativa Pharma Colombia Sas (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Nativa Pharma Colombia Sas Profile Updated: April 09, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Nativa Pharma Colombia Sas is an enterprise in Colombia, with the main office in Bogota D.C.. The enterprise operates in the Pharmaceutical Preparation Manufacturing industry. The company was established on October 07, 2019. It currently has a total number of 6 (2026) employees. There was a net sales revenue drop of 37.71% reported in Nativa Pharma Colombia Sas’s latest financial highlights for 2025. Its’ total assets recorded a growth of 6.19%. The net profit margin of Nativa Pharma Colombia Sas decreased by 28.23% in 2025.

Headquarters
Tv 21 Bis # 59 - 26
Bogota D.C.; Bogota D.C; Postal Code: 0214

Contact Details: Purchase the Nativa Pharma Colombia Sas report to view the information.

Basic Information
Total Employees:
Purchase the Nativa Pharma Colombia Sas report to view the information.
Financial Auditors:
Purchase the Nativa Pharma Colombia Sas report to view the information.
Incorporation Date:
October 07, 2019
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Company Performance
Financial values in the chart are available after Nativa Pharma Colombia Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-37.71%
Total Operating Revenue
-37.71%
Operating Profit
-93.12%
Net Profit/Loss for the Period
-92.27%
Total Assets
6.19%
Total Equity
4.8%
Operating Profit Margin
-32.21%
Net Profit Margin
-28.23%
Return on Equity (ROE)
-42.85%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?